Valued at USD 5.8 Bn in 2024, the market is projected to reach USD 9.8 Bn by 2033, growing at a 8.3% CAGR. The report is segmented by type and end user, and profiles 20 companies including Philips Healthcare, ResMed and Medtronic plc.
The India respiratory devices market was valued at USD 5.8 Bn in 2024 and is projected to reach USD 9.8 Bn by 2033, growing at a CAGR of 8.3%.
India Respiratory Devices Market was valued at USD 5.8 Billion in 2024 and is expected to reach USD 9.8 Billion by 2033, at a CAGR of 8.3% during the forecast period 2024 - 2033.
Disposal gowns are one-time protective garments used by healthcare personnel to avoid contamination and the spread of infectious pathogens during medical operations. Typically composed of nonwoven materials such as polypropylene, they are intended to be destroyed after use to maintain hygiene requirements.
India Respiratory Devices Market Growth Factors
Rising incidence of respiratory disorders
The increased frequency of respiratory illnesses in India is a major driver of the country's respiratory device industry. Urbanisation, air pollution, tobacco smoking, work dangers, and lifestyle changes all contribute to an increase in the prevalence of respiratory disorders.
As the population grows and urbanisation increases air pollution, respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and respiratory infections become increasingly common. Furthermore, lifestyle changes such as sedentary behaviours, poor food choices, and increased stress levels add to the burden of respiratory disorders.
As a result, there is an increased need for respiratory devices that can effectively control and treat these illnesses. These devices include inhalers and nebulizers for treating acute symptoms, as well as continuous positive airway pressure (CPAP) machines and ventilators for severe cases.
Furthermore, technological improvements have resulted in the creation of novel respiratory devices that increase efficacy, convenience of use, and patient comfort, hence boosting market expansion.
With rising awareness of respiratory health and the availability of a diverse variety of respiratory equipment, the Indian respiratory devices market is likely to expand further to suit the population's growing healthcare demands.
These devices include inhalers and nebulizers for treating acute symptoms, as well as continuous positive airway pressure (CPAP) machines and ventilators for severe cases. Furthermore, technological improvements have resulted in the creation of novel respiratory devices that increase efficacy, convenience of use, and patient comfort, hence boosting market expansion.
With rising awareness of respiratory health and the availability of a diverse variety of respiratory equipment, the Indian respiratory devices market is likely to expand further to suit the population's growing healthcare demands. India has 18% of the world's population yet bears 32% of the worldwide burden of respiratory ailments.
A state-level examination of the Global Burden of Disease statistics revealed that the burden of respiratory disease in India is second only to ischemic heart disease. Chronic respiratory disorders accounted for 10.9% of all fatalities.
Rise in geriatric population
The growing elderly population in India is a major driving force behind the country's respiratory device industry. As people become older, they become more vulnerable to respiratory problems and chronic illnesses such as chronic obstructive pulmonary disease (COPD), asthma, and pneumonia.
The ageing process frequently causes weakening respiratory muscles, decreased lung function, and an increased susceptibility to respiratory infections. Furthermore, age-related illnesses such as arthritis and cardiovascular disease might worsen respiratory problems.
With India's demographic change to an increasingly senior population, demand for respiratory equipment is likely to rise. These devices serve an important role in controlling respiratory problems in the elderly, providing treatments ranging from inhalers and nebulizers for sudden symptoms to continuous positive airway pressure (CPAP) machines and oxygen therapy devices for chronic illnesses.
Moreover, technological improvements have resulted in the creation of more portable, user-friendly, and effective respiratory equipment designed to meet the special needs of older persons. As India's senior population grows, so will demand for respiratory equipment, fuelling market expansion.
India Respiratory Devices Market: Restraints
High cost of production
The high production costs are a key obstacle to the expansion of the respiratory devices market in India. This problem is caused by several elements inherent in the production process and the country's economic situation.
The development of innovative respiratory devices frequently necessitates complex technology, specialized materials, and expert labour, all of which contribute to higher production costs.
India, although making technical advances, nevertheless confronts restrictions in terms of indigenous manufacture of some high-tech components and materials necessary for respiratory devices, resulting in reliance on imports, which raises prices owing to customs, taxes, and logistics.
Furthermore, the severe regulatory requirements and quality standards imposed on medical device makers contribute to the production costs, because compliance involves expenditures in research.
Furthermore, market fragmentation and a large percentage of the population's relatively low purchasing power limit economies of scale, making it difficult for manufacturers to realise cost savings through bulk manufacturing.
As a result, these variables combine to raise the cost of respiratory equipment, making them less accessible and affordable to a large segment of the Indian population in need, stifling market growth and worsening healthcare disparities.
To address this issue, strategic initiatives such as fostering domestic manufacturing capabilities, incentivizing R&D, streamlining regulatory processes, and promoting public-private partnerships can help drive down production costs, increase market competitiveness, and improve access to respiratory devices for all segments of the population.
India Respiratory Devices Market: Opportunities
AI-driven respiratory devices
AI-powered linked respiratory devices have transformed the landscape of respiratory treatment in India, causing considerable development in the respiratory device industry.
These revolutionary technologies, which seamlessly integrate artificial intelligence algorithms with respiratory devices, provide personalised, real-time monitoring, diagnostic, and treatment options for respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea.
The introduction of AI-powered linked respiratory devices has improved patient outcomes by allowing for remote monitoring and management of respiratory health, particularly in locations with limited access to healthcare facilities.
Furthermore, the devices' capacity to gather and analyse massive volumes of data on breathing patterns, environmental variables, and treatment reactions provides healthcare practitioners with significant insights for optimising patient care plans.
This data-driven approach not only increases diagnostic speed and accuracy but also allows for preventive treatments to avert exacerbations and problems.
As a result, AI-powered linked respiratory devices have emerged as important growth drivers in the Indian respiratory device market, encouraging increasing use and acceptance of sophisticated respiratory care solutions by both healthcare professionals and patients.
To learn more about this report - request a sample report PDF
India Respiratory Devices Market: Segmentation Analysis
India Respiratory Devices market is segmented by type, end user and region. Based on type, the market is classified into respiratory consumables, nebulizers, and oxygen concentrators. Oxygen Concentrators dominated the market in 2023 with a market share of 55.3% and are expected to keep their dominance during the forecast period 2024-2033.
Oxygen concentrators have emerged as a key driver in India's respiratory devices industry, causing substantial development and transformation. These devices serve an important role in administering supplementary oxygen treatment to patients suffering from respiratory illnesses such as chronic obstructive pulmonary disease (COPD), asthma, and respiratory distress syndrome.
India, with its large population and high prevalence of respiratory disorders, has seen an increase in demand for oxygen concentrators, particularly during health emergencies like the COVID-19 pandemic.
Unlike traditional oxygen cylinders, which require regular refilling and pose logistical challenges, oxygen concentrators extract oxygen from ambient air using advanced filtration and concentration technologies, providing a continuous and dependable oxygen supply without the need for frequent replenishment.
Furthermore, the growing desire for home-based care and remote monitoring solutions, fuelled by factors such as rising healthcare costs and an ageing population, has accelerated the use of oxygen concentrators as an essential respiratory treatment solution.
Based on end user, the market is classified into hospitals, clinics, and ambulatory surgical centers. Hospitals dominated the market in 2023 with a market share of 53.1% and are expected to keep their dominance during the forecast period 2024-2033. Hospitals play an important role in driving the respiratory devices market in India because they require modern medical equipment to diagnose, treat, and manage respiratory diseases.
As India faces issues such as air pollution and a rising prevalence of respiratory disorders including asthma, chronic obstructive pulmonary disease (COPD), and pneumonia, hospitals remain the primary site of care for patients seeking respiratory health services.
To accommodate the increased need for respiratory treatment, hospitals invest in a variety of technologies such as ventilators, CPAP machines, nebulizers, oxygen concentrators, and spirometers. These devices are crucial for giving life-saving measures, assisting patients during critical care, and enhancing respiratory function.
Furthermore, the COVID-19 pandemic has highlighted the vital role of respiratory devices in controlling respiratory distress caused by the virus, accelerating the use of these technologies in hospitals across India.
With an increasing emphasis on improving healthcare infrastructure and expanding access to quality medical services, hospitals remain significant drivers of growth in the Indian respiratory devices market, fostering innovation and driving advancements in respiratory care technology to improve patient outcomes and address the population's changing healthcare needs.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 5.8 Billion |
| Projected Market Size in 2033 | USD 9.8 Billion |
| Market Size in 2023 | USD 5.4 Billion |
| CAGR Growth Rate | 8.3% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Type, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Country Scope | India |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
India Respiratory Devices Market: Recent Developments
Source: Custom Market Insights analysis.
To learn more about this report - request a sample report PDF
List of the prominent players in the India Respiratory Devices Market:
These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The India Respiratory Devices Market is segmented as follows:
Updated: January 2026 · Formats: PDF, Excel, PPT
The restraints of the India Respiratory Devices market is high cost of production.
The major driver for the India Respiratory Devices market is rising incidence of respiratory disorders and rise in geriatric population.
The "Respiratory Consumables" category dominated the market in 2023.
The key players in the market are Philips Healthcare, ResMed, Medtronic plc, Fisher & Paykel Healthcare, GE Healthcare, Drägerwerk AG & Co. KGaA, Hamilton Medical, Masimo Corporation, Vyaire Medical, Air Liquide, Smiths Medical, Invacare Corporation, Mindray Medical International Limited, Becton Dickinson and Company , Maquet Holding B.V. & Co. KG , Allied Healthcare Products Inc., DeVilbiss Healthcare, Drive DeVilbiss Healthcare, Teleflex Incorporated, Airon Corporation, Others.
The market is projected to grow at a CAGR of 8.3% during the forecast period, 2024-2033.
The India Respiratory Devices Market size was valued at USD 5.8 Billion in 2024.
Author · Sr. Research Analyst
Ayush Kadam is a Senior Market Research Analyst at Custom Market Insights, with over seven years of experience in syndicated and custom market research. He specializes in market sizing, competitive intelligence, industry trends, forecasting, and strategic insights, helping clients turn complex data into actionable business decisions.
Buy individual chapters for $490 each: 9 chapters available, from Executive Summary to Company Profiles.
Get the full report structure, sample pages and data tables in the free sample.
Download free sampleGet the full report structure, sample pages and data tables in the free sample.
Download free sampleGet the full report structure, sample pages and data tables in the free sample.
Download free sample